RBC Capital Starts Spectrum Pharmaceuticals (SPPI) at Outperform
Tweet
Share
E-mailGet Alerts SPPI Hot Sheet
Price: $1.03 --0%
Rating Summary:
3 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Rating Summary:
3 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Join SI Premium – FREE
RBC Capital initiates coverage on Spectrum Pharmaceuticals (NASDAQ: SPPI) with an Outperform. PT $12.
For more ratings news on Spectrum Pharmaceuticals click here and for the rating history of Spectrum Pharmaceuticals click here.
Shares of Spectrum Pharmaceuticals closed at $8.33 yesterday.
For more ratings news on Spectrum Pharmaceuticals click here and for the rating history of Spectrum Pharmaceuticals click here.
Shares of Spectrum Pharmaceuticals closed at $8.33 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Starts Krystal Biotech (KRYS) at Outperform
- Truist Securities Reinstates Pacira Pharmaceuticals (PCRX) at Buy
- Needham Starts Pulse Biosciences (PLSE) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
